ZimVie Inc. (ZIMV)
- Previous Close
8.69 - Open
8.70 - Bid 6.38 x 200
- Ask 11.03 x 200
- Day's Range
8.55 - 9.02 - 52 Week Range
8.55 - 22.40 - Volume
260,656 - Avg. Volume
153,880 - Market Cap (intraday)
251.573M - Beta (5Y Monthly) 2.02
- PE Ratio (TTM)
-- - EPS (TTM)
-0.90 - Earnings Date Jul 31, 2025 - Aug 4, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.67
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including dental service organizations, as well as educational, medical and governmental entities, hospitals, and surgery centers through sales representatives, independent sales agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Palm Beach Gardens, Florida.
www.zimvie.comRecent News: ZIMV
View More
Performance Overview: ZIMV
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ZIMV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ZIMV
View MoreValuation Measures
Market Cap
251.57M
Enterprise Value
417.53M
Trailing P/E
--
Forward P/E
11.15
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.64
Enterprise Value/Revenue
0.94
Enterprise Value/EBITDA
11.32
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.40%
Return on Assets (ttm)
0.04%
Return on Equity (ttm)
-6.37%
Revenue (ttm)
443.55M
Net Income Avi to Common (ttm)
-24.97M
Diluted EPS (ttm)
-0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
66.75M
Total Debt/Equity (mrq)
58.89%
Levered Free Cash Flow (ttm)
216.3M
Research Analysis: ZIMV
View MoreResearch Reports: ZIMV
View MoreWhat does Argus have to say about ZIMV?
ZIMVIE INC has an Investment Rating of HOLD; a target price of $6.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $6.00
ZIMVIE INC has an Investment Rating of HOLD; a target price of $6.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetWhat does Argus have to say about ZIMV?
ZIMVIE INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetLowering target price to $11.00
ZIMVIE INC has an Investment Rating of HOLD; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target